Diagnostic efficacy of serum 1,3-beta-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies

作者：Lu Xiaoling; Tang Tingyu; Hu Caibao; Zhao Tian; Chen Changqin^*

来源：Open Medicine, 2018, 13(1): 329-337.

DOI：10.1515/med-2018-0050

• 1,3-beta-D-glucan
• invasive fungal infection
• meta-analysis
• diagnosis

Objective The aim of this study was to investigate the diagnostic performance of serum 1,3-beta-D-glucan as biomarker for invasive fungal infection through meta-analysis.
Methods The electronic databases of Medline, Cochrane, Embase, Web of Science, OVID and CNKI were systematic searched to identified the case-control or Cohort studies relevant to diagnostic efficacy of serum 1,3-beta-D-glucan for invasive fungal infection. The data of true positive (tp), false positive (fp), false negative (fn) and true negative (tn) patients number were extracted from each of the original included studies. The diagnostic sensitivity, specificity and systematic receiver operating characteristic (SROC) curve were calculated and pooled through random or fixed effect method. The publication bias was evaluated by the Deek's funnel plot.
Results Thirty-seven relevant studies were fulfilled the inclusion criteria and included in our present meta-analysis. The combined sensitivity, specificity, positive likely hood ratio (+ lr), negative likely hood ratio (-lr) and diagnostic odds ratio(dor) for 1,3-beta-D-glucan in diagnosis of invasive fungal infectionwere 0.83 (95% CI: 0.38-0.61), 0.81 (95% CI: 0.80-0.82), 5.13 (95% CI: 3.98-6.62), 0.23 (95% CI: 0.18-0.30), and 29.68 (95% CI: 18.94-46.52) respectively. The pooled area under the ROC curve (AUC) was 0.91. The Deek's funnel plot asymmetry test showed there was no publication bias for 1,3-beta-D-glucan in diagnosis of invasive fungal infection of the included 37 studies. '
Conclusion Serum 1,3-beta-D-glucan assay was a promising biomarker for invasive fungal infection diagnosis.

• 出版日期2018
• 单位浙江医院